Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

BACKGROUND: Influenza causes substantial morbidity and mortality despite available treatments. Anecdotal reports suggest that plasma with high antibody titres to influenza might be of benefit in the treatment of severe influenza. METHODS: In this randomised, open-label, multicentre, phase 2 trial, 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Respir Med
Principais autores: Beigel, John H, Tebas, Pablo, Elie-Turenne, Marie-Carmelle, Bajwa, Ednan, Bell, Todd E, Cairns, Charles B, Shoham, Shmuel, Deville, Jaime G, Feucht, Eric, Feinberg, Judith, Luke, Thomas, Raviprakash, Kanakatte, Danko, Janine, O'Neil, Dorothy, Metcalf, Julia A, King, Karen, Burgess, Timothy H, Aga, Evgenia, Lane, H Clifford, Hughes, Michael D, Davey, Richard T
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Ltd. 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828518/
https://ncbi.nlm.nih.gov/pubmed/28522352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(17)30174-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados